Latest Insider Transactions at Navidea Biopharmaceuticals, Inc. (NAVB)
This section provides a real-time view of insider transactions for Navidea Biopharmaceuticals, Inc. (NAVB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NAVIDEA BIOPHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NAVIDEA BIOPHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 28
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
Feb 28
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.71%
|
-
|
Jan 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.94%
|
-
|
Jan 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+5.38%
|
-
|
Jan 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
Jan 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.74%
|
-
|
Jan 14
2022
|
Michael Stanley Rosol Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,728
+34.65%
|
-
|
Dec 31
2021
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+5.2%
|
-
|
Dec 31
2021
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+5.68%
|
-
|
Dec 31
2021
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
Dec 31
2021
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.77%
|
-
|
Nov 30
2021
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.91%
|
-
|
Nov 30
2021
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+2.82%
|
-
|
Nov 30
2021
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+3.11%
|
-
|
Nov 30
2021
|
Thomas F Farb Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+3.6%
|
-
|
Nov 30
2021
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.02%
|
-
|
Nov 30
2021
|
Agnieszka Winkler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+3.59%
|
-
|
Nov 15
2021
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,886
+10.29%
|
-
|
Nov 15
2021
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,623
+24.63%
|
-
|
Nov 15
2021
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,965
+28.28%
|
-
|
Nov 15
2021
|
Thomas F Farb Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,175
+28.17%
|
-
|
Nov 15
2021
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
32,483
+0.2%
|
-
|
Nov 15
2021
|
Agnieszka Winkler Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,350
+28.39%
|
-
|
Sep 30
2021
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,995
+3.76%
|
-
|
Sep 30
2021
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,762
+50.0%
|
-
|
Sep 30
2021
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,286
+31.79%
|
-
|
Sep 17
2021
|
Malcolm G Witter Director |
BUY
Open market or private purchase
|
Direct |
20,000
+16.91%
|
$20,000
$1.6 P/Share
|
Jul 26
2021
|
Malcolm G Witter Director |
BUY
Open market or private purchase
|
Direct |
15,000
+16.08%
|
$15,000
$1.7 P/Share
|
Jun 30
2021
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,409
+32.92%
|
-
|
Jun 30
2021
|
Claudine Bruck Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,969
+19.37%
|
-
|
Jun 30
2021
|
Sarah Kathryn Rouan Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,892
+21.15%
|
-
|
Jun 30
2021
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,757
+5.61%
|
-
|
May 04
2021
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
Apr 23
2021
|
Malcolm G Witter Director |
BUY
Open market or private purchase
|
Direct |
10,000
+14.93%
|
$10,000
$1.6 P/Share
|
Mar 29
2021
|
Malcolm G Witter Director |
BUY
Open market or private purchase
|
Direct |
21,500
+31.39%
|
$43,000
$2.07 P/Share
|
Mar 03
2021
|
Malcolm G Witter Director |
BUY
Open market or private purchase
|
Direct |
15,000
+37.04%
|
$30,000
$2.31 P/Share
|
Jan 13
2021
|
Claudine Bruck Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+16.61%
|
-
|
Jan 13
2021
|
Adam D. Cutler Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+20.0%
|
-
|
Jan 13
2021
|
Yehuda Michael Rice Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+16.67%
|
-
|
Jan 13
2021
|
Sarah Kathryn Rouan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+15.77%
|
-
|
Jan 13
2021
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+16.13%
|
-
|
Dec 28
2020
|
Malcolm G Witter Director |
BUY
Open market or private purchase
|
Direct |
5,000
+32.26%
|
$10,000
$2.07 P/Share
|